Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Dec 21;12(1):15.
doi: 10.3390/microorganisms12010015.

Intersociety Position Statement on the Prevention of Ophthalmia Neonatorum in Italy

Affiliations

Intersociety Position Statement on the Prevention of Ophthalmia Neonatorum in Italy

Chryssoula Tzialla et al. Microorganisms. .

Abstract

There is currently no worldwide agreement on the real need to administer conjunctival antibiotics to neonates at birth to prevent neonatal conjunctivitis (usually defined as ophthalmia neonatorum) by Chlamydia trachomatis and Neisseria gonorrhoeae. Therefore, there is wide variability in antibiotic administration, conditioned mainly by the social and health context. In Italy, a law enacted in 1940 required doctors and midwives to administer ophthalmic prophylaxis with 2% silver nitrate to all newborns at birth. This law was repealed in 1975 and since then there has been no clear guidance on the use of ophthalmia neonatorum prophylaxis at birth. Since neonatal conjunctivitis caused by C. trachomatis and N. gonorrhoeae is not reported, we carried out a nationwide survey of 1,041,384 neonates across all Italian birth centers to evaluate the incidence of ophthalmia neonatorum and the current practice of prophylaxis. After analyzing the results, we formulated an intersociety position statement on the prevention of ophthalmia neonatorum to update and standardize this prevention strategy in Italy.

Keywords: Chlamydia trachomatis; Neisseria gonorrhoeae; neonatal ocular prophylaxis; ophthalmia neonatorum.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Recommendations flow chart [22,23,25,28,42,43,44,45,46,47].

References

    1. American Academy of Pediatrics . Committee on Infectious Diseases. Neonatal ophthalmia. In: Kimberlin D.W., Barnett E.D., Lynfield R., Sawyer M.H., editors. Red Book: 2021–2024 Report of the Committee on Infectious Diseases. 32nd ed. American Academy of Pediatrics; Itasca, IL, USA: 2021. pp. 1023–1026.
    1. Kapoor V.S., Evans J.R., Vedula S.S. Interventions for preventing ophthalmia neonatorum. Cochrane Database Syst. Rev. 2020;9:CD001862. doi: 10.1002/14651858.CD001862.pub4. - DOI - PMC - PubMed
    1. Nolt D., O’Leary S.T., Aucott S.W. Risks of infectious diseases in newborns exposed to alternative perinatal practices. AAP Committee on Infectious Diseases, AAP Committee on Fetus and Newborn. Pediatrics. 2022;149:e2021055554. doi: 10.1542/peds.2021-055554. - DOI - PMC - PubMed
    1. Credé C.S. Ophthalmia neonatorum in newborn children [Die verhub rtung der augenentzub ndung der neugeborenen] Archiv. Gynaekol. 1881;17:50–53.
    1. Forbes G.B., Forbes G.M. Silver nitrate and the eye of the newborn. Credé’s contribution to preventive medicine. Am. J. Dis. Child. 1971;121:1–3. doi: 10.1001/archpedi.1971.02100120037001. - DOI - PubMed